Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03387020
Title Ribociclib and Everolimus in Treating Children With Recurrent or Refractory Malignant Brain Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Pediatric Brain Tumor Consortium
Indications

central nervous system embryonal carcinoma

malignant glioma

brain stem cancer

brain stem glioma

medulloblastoma

atypical teratoid rhabdoid tumor

malignant ependymoma

Therapies

Ribociclib

Everolimus + Ribociclib

Age Groups: child | adult
Covered Countries USA


No variant requirements are available.